National Health Investors
233 hedge funds and large institutions have $1.37B invested in National Health Investors in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 83 increasing their positions, 81 reducing their positions, and 39 closing their positions.
81% more call options, than puts
Call options by funds: $2.34M | Put options by funds: $1.29M
2% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 81
0.06% more ownership
Funds ownership: 61.92% → 61.98% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 242 → 233 (-9)
12% less capital invested
Capital invested by funds: $1.56B → $1.37B (-$190M)
13% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$18.8M |
| 2 |
Millennium Management
New York
|
+$8.69M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$8.29M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.16M |
| 5 |
Renaissance Technologies
New York
|
+$7.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$54.2M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$11.3M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
-$9.87M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.36M |
| 5 |
Comerica Bank
Dallas,
Texas
|
-$7.27M |
NHI Hedge Fund Activity: Q4 2022 in Review
233 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in National Health Investors (NHI) for Q4 2022, worth a combined $1.37B — down 12% from $1.56B a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of NHI and 34 opened new positions — a net loss of 5 holders — while 81 trimmed existing stakes and 83 added.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $18.8M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $54.2M sold.
- 233 institutional investors held National Health Investors (NHI) as of Q4 2022, down from 242 in Q3 2022.
- Funds reported $1.37B of National Health Investors stock for Q4 2022, down 12% quarter-over-quarter.
- 34 funds opened new National Health Investors positions in Q4 2022 and 39 closed out, a net change of -5 holders.
- The largest National Health Investors buyer in Q4 2022 was Balyasny Asset Management, an estimated $18.8M added.
- The largest National Health Investors seller in Q4 2022 was Westfield Capital Management, an estimated $54.2M sold.
Based on aggregated 13F filings for Q4 2022.